Min Bao

Min Bao, MD, is Chief Medical Officer and Co-Founder of Kali Therapeutics, where she leads clinical development strategy for the company’s next-generation T-cell engager therapies targeting autoimmune diseases. She brings over 25 years of drug development experience across large pharmaceutical companies and emerging biotechnology organizations, with expertise spanning immunology, oncology, and clinical development. Prior to co-founding Kali Therapeutics, Min held senior clinical leadership roles at companies including AnaptysBio, Alpine Immune Sciences (a Vertex company), and Annexon Biosciences, where she led development programs across multiple therapeutic areas